➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Colorcon
Medtronic
McKinsey
Express Scripts

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Rauwolfia serpentina root - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for rauwolfia serpentina root and what is the scope of patent protection?

Rauwolfia serpentina root is the generic ingredient in eight branded drugs marketed by Bowman Pharms, Phys Prods Va, Panray, Apothecon, Ferndale Labs, Pal Pak, Bundy, Halsey, Impax Labs, Ivax Sub Teva Pharms, Purepac Pharm, Pvt Form, Solvay, Tablicaps, Valeant Pharm Intl, Watson Labs, and Forest Pharms, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for rauwolfia serpentina root.

Summary for rauwolfia serpentina root
Recent Clinical Trials for rauwolfia serpentina root

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Heart, Lung, and Blood Institute (NHLBI)Phase 3

See all rauwolfia serpentina root clinical trials

US Patents and Regulatory Information for rauwolfia serpentina root

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 080500-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ferndale Labs RAUSERPIN rauwolfia serpentina root TABLET;ORAL 009926-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Valeant Pharm Intl RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 009668-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bowman Pharms HIWOLFIA rauwolfia serpentina root TABLET;ORAL 009276-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bowman Pharms HIWOLFIA rauwolfia serpentina root TABLET;ORAL 009276-005 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 080500-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pal Pak RAUVAL rauwolfia serpentina root TABLET;ORAL 009108-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Colorcon
Medtronic
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.